ClinicalTrials.Veeva

Menu

Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival

H

Huazhong University of Science and Technology

Status

Completed

Conditions

ccRCC

Study type

Observational

Funder types

Other

Identifiers

NCT06791863
0361-02

Details and patient eligibility

About

This retrospective study included 1030 patients with clear cell renal cell carcinoma (ccRCC) who underwent radical or partial nephrectomy at Wuhan Union Hospital from 2014 to 2023.

Enrollment

1,030 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. primary clear cell renal cell carcinoma confirmed by histopathology;
  2. patients≥18 years;
  3. availability of preoperative abdominal computed tomography (CT) data;
  4. patients with partial or radical nephrectomy.

Trial design

1,030 participants in 2 patient groups

Cohort 1
Description:
The group with high area of body compositions (skeletal muscle, subcutaneous fat, subcutaneous fat or total fat)
Cohort 2
Description:
the group with low area of body compositions (skeletal muscle, subcutaneous fat, subcutaneous fat or total fat)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems